메뉴 건너뛰기




Volumn 17, Issue 17, 2011, Pages 5801-5811

Genetic variation predicting cisplatin cytotoxicity associated with overall survival in lung cancer patients receiving platinum-based chemotherapy

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; CISPLATIN; DEATH ASSOCIATED PROTEIN KINASE; DEATH ASSOCIATED PROTEIN KINASE 3; DNA; PLATINUM DERIVATIVE; PROTEIN METTL6; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

EID: 80052442469     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-11-1133     Document Type: Article
Times cited : (91)

References (46)
  • 1
    • 0028843552 scopus 로고
    • Chemotherapy in non-small cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomised clinical trials
    • Non-small Cell Lung Cancer Collaborative Group
    • Chemotherapy in non-small cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomised clinical trials. Non-small Cell Lung Cancer Collaborative Group. BMJ 1995;311:899-909.
    • (1995) BMJ , vol.311 , pp. 899-909
  • 3
    • 56149087582 scopus 로고    scopus 로고
    • Germline genetic variations in drug action pathways predict clinical outcomes in advanced lung cancer treated with platinum-based chemotherapy
    • Wu X., Lu C., Ye Y., Chang J., Yang H., Lin J., et al. Germline genetic variations in drug action pathways predict clinical outcomes in advanced lung cancer treated with platinum-based chemotherapy. Pharmacogenet Genomics 2008;18:955-965
    • (2008) Pharmacogenet Genomics , vol.18 , pp. 955-965
    • Wu, X.1    Lu, C.2    Ye, Y.3    Chang, J.4    Yang, H.5    Lin, J.6
  • 4
    • 79952251471 scopus 로고    scopus 로고
    • Predictive value of ERCC1 and XPD polymorphism in patients with advanced non-small cell lung cancer receiving platinum-based chemotherapy: A systematic review and meta-analysis
    • Wei S.Z., Zhan P., Shi M.Q., Shi Y., Qian Q., Yu L.K., et al. Predictive value of ERCC1 and XPD polymorphism in patients with advanced non-small cell lung cancer receiving platinum-based chemotherapy: A systematic review and meta-analysis. Med Oncol 2010;28:315-321
    • (2010) Med Oncol , vol.28 , pp. 315-321
    • Wei, S.Z.1    Zhan, P.2    Shi, M.Q.3    Shi, Y.4    Qian, Q.5    Yu, L.K.6
  • 5
    • 58849149494 scopus 로고    scopus 로고
    • Pharmacogenetics and pharmacogenomics of anticancer agents
    • Huang R.S., Ratain M.J. Pharmacogenetics and pharmacogenomics of anticancer agents. CA Cancer J Clin 2009;59:42-55.
    • (2009) CA Cancer J Clin , vol.59 , pp. 42-55
    • Huang, R.S.1    Ratain, M.J.2
  • 8
    • 34247882838 scopus 로고    scopus 로고
    • Glutathione-S-transferase P1 isoenzyme polymorphisms, platinum-based chemotherapy, and non-small cell lung cancer
    • PII 0124389420060900000013
    • Booton R., Ward T., Heighway J., Ashcroft L., Morris J., Thatcher N. Glutathione-S-transferase P1 isoenzyme polymorphisms, platinum-based chemotherapy, and non-small cell lung cancer. J Thorac Oncol 2006;1:679-683 (Pubitemid 47163956)
    • (2006) Journal of Thoracic Oncology , vol.1 , Issue.7 , pp. 679-683
    • Booten, R.1    Ward, T.2    Heighway, J.3    Ashcroft, L.4    Morris, J.5    Thatcher, N.6
  • 9
    • 30744451927 scopus 로고    scopus 로고
    • Association between glutathione S-transferase pi polymorphisms and survival in patients with advanced nonsmall cell lung carcinoma
    • DOI 10.1002/cncr.21619
    • Lu C., Spitz M.R., Zhao H., Dong Q., Truong M., Chang J.Y., et al. Association between glutathione S-transferase pi polymorphisms and survival in patients with advanced nonsmall cell lung carcinoma. Cancer 2006;106:441-447 (Pubitemid 43100456)
    • (2006) Cancer , vol.106 , Issue.2 , pp. 441-447
    • Lu, C.1    Spitz, M.R.2    Zhao, H.3    Dong, Q.4    Truong, M.5    Chang, J.Y.6    Blumenschein Jr., G.R.7    Hong, W.K.8    Wu, X.9
  • 10
    • 77949674534 scopus 로고    scopus 로고
    • Glutathione pathway genetic polymorphisms and lung cancer survival after platinum-based chemotherapy
    • Moyer A.M., Sun Z., Batzler A.J., Li L., Schaid D.J., Yang P., et al. Glutathione pathway genetic polymorphisms and lung cancer survival after platinum-based chemotherapy. Cancer Epidemiol Biomarkers Prev 2010;19:811-821
    • (2010) Cancer Epidemiol Biomarkers Prev , vol.19 , pp. 811-821
    • Moyer, A.M.1    Sun, Z.2    Batzler, A.J.3    Li, L.4    Schaid, D.J.5    Yang, P.6
  • 11
    • 58049209898 scopus 로고    scopus 로고
    • Effect of BRCA1 haplotype on survival of non-small-cell lung cancer patients treated with platinum-based chemotherapy
    • Kim H.T., Lee J.E., Shin E.S., Yoo Y.K., Cho J.H., Yun M.H., et al. Effect of BRCA1 haplotype on survival of non-small-cell lung cancer patients treated with platinum-based chemotherapy. J Clin Oncol 2008;26:5972-5979
    • (2008) J Clin Oncol , vol.26 , pp. 5972-5979
    • Kim, H.T.1    Lee, J.E.2    Shin, E.S.3    Yoo, Y.K.4    Cho, J.H.5    Yun, M.H.6
  • 12
    • 78049423379 scopus 로고    scopus 로고
    • Association between polymorphisms of ERCC1 and XPD and clinical response to platinum-based chemotherapy in advanced non-small cell lung cancer
    • Li F., Sun X., Sun N., Qin S., Cheng H., Feng J., et al. Association between polymorphisms of ERCC1 and XPD and clinical response to platinum-based chemotherapy in advanced non-small cell lung cancer. Am J Clin Oncol 2010;33:489-494
    • (2010) Am J Clin Oncol , vol.33 , pp. 489-494
    • Li, F.1    Sun, X.2    Sun, N.3    Qin, S.4    Cheng, H.5    Feng, J.6
  • 13
    • 79957745242 scopus 로고    scopus 로고
    • Assessment of XPD Lys751Gln and XRCC1 T-77C polymorphisms in advanced non-small-cell lung cancer patients treated with platinum-based chemotherapy
    • Liu L., Yuan P., Wu C., Zhang X., Wang F., Guo H., et al. Assessment of XPD Lys751Gln and XRCC1 T-77C polymorphisms in advanced non-small-cell lung cancer patients treated with platinum-based chemotherapy. Lung Cancer 2011;73:110-115
    • (2011) Lung Cancer , vol.73 , pp. 110-115
    • Liu, L.1    Yuan, P.2    Wu, C.3    Zhang, X.4    Wang, F.5    Guo, H.6
  • 15
    • 79951875424 scopus 로고    scopus 로고
    • Association of DNA repair gene polymorphisms with response to platinum-based doublet chemotherapy in patients with non-small-cell lung cancer
    • Shiraishi K., Kohno T., Tanai C., Goto Y., Kuchiba A., Yamamoto S., et al. Association of DNA repair gene polymorphisms with response to platinum-based doublet chemotherapy in patients with non-small-cell lung cancer. J Clin Oncol 2010;28:4945-4952
    • (2010) J Clin Oncol , vol.28 , pp. 4945-4952
    • Shiraishi, K.1    Kohno, T.2    Tanai, C.3    Goto, Y.4    Kuchiba, A.5    Yamamoto, S.6
  • 16
    • 67449162069 scopus 로고    scopus 로고
    • Polymorphisms in XRCC1 and XPG and response to platinum-based chemotherapy in advanced non-small cell lung cancer patients
    • Sun X., Li F., Sun N., Shukui Q., Baoan C., Jifeng F., et al. Polymorphisms in XRCC1 and XPG and response to platinum-based chemotherapy in advanced non-small cell lung cancer patients. Lung Cancer 2009;65:230-236
    • (2009) Lung Cancer , vol.65 , pp. 230-236
    • Sun, X.1    Li, F.2    Sun, N.3    Shukui, Q.4    Baoan, C.5    Jifeng, F.6
  • 21
    • 52049100798 scopus 로고    scopus 로고
    • Gemcitabine and cytosine arabinoside cytotoxicity: Association with lymphoblastoid cell expression
    • Li L., Fridley B., Kalari K., Jenkins G., Batzler A., Safgren S., et al. Gemcitabine and cytosine arabinoside cytotoxicity: Association with lymphoblastoid cell expression. Cancer Res 2008;68:7050-7058
    • (2008) Cancer Res , vol.68 , pp. 7050-7058
    • Li, L.1    Fridley, B.2    Kalari, K.3    Jenkins, G.4    Batzler, A.5    Safgren, S.6
  • 22
    • 70450189297 scopus 로고    scopus 로고
    • Gemcitabine and arabinosylcytosin pharmacogenomics: Genomewide association and drug response biomarkers
    • Li L., Fridley B.L., Kalari K., Jenkins G., Batzler A., Weinshilboum R.M., et al. Gemcitabine and arabinosylcytosin pharmacogenomics: Genomewide association and drug response biomarkers. PLoS One 2009;4:e7765.
    • (2009) PLoS One , vol.4
    • Li, L.1    Fridley, B.L.2    Kalari, K.3    Jenkins, G.4    Batzler, A.5    Weinshilboum, R.M.6
  • 23
    • 78649300012 scopus 로고    scopus 로고
    • Radiation pharmacogenomics: A genome-wide association approach to identify radiation response biomarkers using human lymphoblastoid cell lines
    • Niu N., Qin Y., Fridley B.L., Hou J., Kalari K.R., Zhu M., et al. Radiation pharmacogenomics: A genome-wide association approach to identify radiation response biomarkers using human lymphoblastoid cell lines. Genome Res 2010;20:1482-1492
    • (2010) Genome Res , vol.20 , pp. 1482-1492
    • Niu, N.1    Qin, Y.2    Fridley, B.L.3    Hou, J.4    Kalari, K.R.5    Zhu, M.6
  • 26
    • 33845225116 scopus 로고    scopus 로고
    • Exact tests of Hardy-Weinberg equilibrium and homogeneity of disequilibrium across strata
    • DOI 10.1086/510257
    • Schaid D.J., Batzler A.J., Jenkins G.D., Hildebrandt M.A. Exact tests of Hardy-Weinberg equilibrium and homogeneity of disequilibrium across strata. Am J Hum Genet 2006;79:1071-1080 (Pubitemid 44853478)
    • (2006) American Journal of Human Genetics , vol.79 , Issue.6 , pp. 1071-1080
    • Schaid, D.J.1    Batzler, A.J.2    Jenkins, G.D.3    Hildebrandt, M.A.T.4
  • 27
    • 84969213492 scopus 로고    scopus 로고
    • Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls
    • Wellcome Trust Case Control Consortium
    • Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007;447:661-678
    • (2007) Nature , vol.447 , pp. 661-678
  • 28
    • 77954531945 scopus 로고    scopus 로고
    • A quality control algorithm for filtering SNPs in genome-wide association studies
    • Pongpanich M., Sullivan P.F., Tzeng J.Y. A quality control algorithm for filtering SNPs in genome-wide association studies. Bioinformatics 2010;26:1731-1737
    • (2010) Bioinformatics , vol.26 , pp. 1731-1737
    • Pongpanich, M.1    Sullivan, P.F.2    Tzeng, J.Y.3
  • 29
    • 33746512512 scopus 로고    scopus 로고
    • Principal components analysis corrects for stratification in genome-wide association studies
    • DOI 10.1038/ng1847, PII NG1847
    • Price A.L., Patterson N.J., Plenge R.M., Weinblatt M.E., Shadick N.A., Reich D. Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 2006;38:904-909 (Pubitemid 44141658)
    • (2006) Nature Genetics , vol.38 , Issue.8 , pp. 904-909
    • Price, A.L.1    Patterson, N.J.2    Plenge, R.M.3    Weinblatt, M.E.4    Shadick, N.A.5    Reich, D.6
  • 30
    • 78649508578 scopus 로고    scopus 로고
    • MaCH: Using sequence and genotype data to estimate haplotypes and unobserved genotypes
    • Li Y., Willer C.J., Ding J., Scheet P., Abecasis G.R. MaCH: Using sequence and genotype data to estimate haplotypes and unobserved genotypes. Genet Epidemiol 2010;34:816-834
    • (2010) Genet Epidemiol , vol.34 , pp. 816-834
    • Li, Y.1    Willer, C.J.2    Ding, J.3    Scheet, P.4    Abecasis, G.R.5
  • 32
    • 4143051317 scopus 로고    scopus 로고
    • Excision repair cross-complementation group 1 polymorphism predicts overall survival in advanced non-small cell lung cancer patients treated with platinum-based chemotherapy
    • DOI 10.1158/1078-0432.CCR-04-0247
    • Zhou W., Gurubhagavatula S., Liu G., Park S., Neuberg D.S., Wain J.C., et al. Excision repair cross-complementation group 1 polymorphism predicts overall survival in advanced non-small cell lung cancer patients treated with platinum-based chemotherapy. Clin Cancer Res 2004;10:4939-4943 (Pubitemid 39099767)
    • (2004) Clinical Cancer Research , vol.10 , Issue.15 , pp. 4939-4943
    • Zhou, W.1    Gurubhagavatula, S.2    Liu, G.3    Park, S.4    Neuberg, D.S.5    Wain, J.C.6    Lynch, T.J.7    Su, L.8    Christiani, D.C.9
  • 34
    • 40049084479 scopus 로고    scopus 로고
    • Susceptibility loci involved in cisplatin-induced cytotoxicity and apoptosis
    • DOI 10.1097/FPC.0b013e3282f5e605, PII 0121301120080300000010
    • Shukla S.J., Duan S., Badner J.A., Wu X., Dolan M.E. Susceptibility loci involved in cisplatin-induced cytotoxicity and apoptosis. Pharmacogenet Genomics 2008;18:253-262 (Pubitemid 351323240)
    • (2008) Pharmacogenetics and Genomics , vol.18 , Issue.3 , pp. 253-262
    • Shukla, S.J.1    Duan, S.2    Badner, J.A.3    Wu, X.4    Dolan, M.E.5
  • 35
    • 54049083902 scopus 로고    scopus 로고
    • Genetic variants associated with carboplatin-induced cytotoxicity in cell lines derived from Africans
    • Huang R.S., Duan S., Kistner E.O., Hartford C.M., Dolan M.E. Genetic variants associated with carboplatin-induced cytotoxicity in cell lines derived from Africans. Mol Cancer Ther 2008;7:3038-3046
    • (2008) Mol Cancer Ther , vol.7 , pp. 3038-3046
    • Huang, R.S.1    Duan, S.2    Kistner, E.O.3    Hartford, C.M.4    Dolan, M.E.5
  • 36
    • 65249086733 scopus 로고    scopus 로고
    • Whole-genome approach implicates CD44 in cellular resistance to carboplatin
    • Shukla S.J., Duan S., Wu X., Badner J.A., Kasza K., Dolan M.E. Whole-genome approach implicates CD44 in cellular resistance to carboplatin. Hum Genomics 2009;3:128-142
    • (2009) Hum Genomics , vol.3 , pp. 128-142
    • Shukla, S.J.1    Duan, S.2    Wu, X.3    Badner, J.A.4    Kasza, K.5    Dolan, M.E.6
  • 37
    • 57149114316 scopus 로고    scopus 로고
    • Genetic analysis of human traits in vitro: Drug response and gene expression in lymphoblastoid cell lines
    • Choy E., Yelensky R., Bonakdar S., Plenge R.M., Saxena R., De Jager P.L., et al. Genetic analysis of human traits in vitro: Drug response and gene expression in lymphoblastoid cell lines. PLoS Genet 2008;4:e1000287.
    • (2008) PLoS Genet , vol.4
    • Choy, E.1    Yelensky, R.2    Bonakdar, S.3    Plenge, R.M.4    Saxena, R.5    De Jager, P.L.6
  • 38
  • 41
    • 35948986807 scopus 로고    scopus 로고
    • ZIPK: A unique case of murine-specific divergence of a conserved vertebrate gene
    • DOI 10.1371/journal.pgen.0030180
    • Shoval Y., Pietrokovski S., Kimchi A. ZIPK: A unique case of murine-specific divergence of a conserved vertebrate gene. PLoS Genet 2007;3:1884-1893 (Pubitemid 350072054)
    • (2007) PLoS Genetics , vol.3 , Issue.10 , pp. 1884-1893
    • Shoval, Y.1    Pietrokovski, S.2    Kimchi, A.3
  • 42
    • 0035835823 scopus 로고    scopus 로고
    • DAP kinase - A proapoptotic gene that functions as a tumor suppressor
    • DOI 10.1006/excr.2000.5134
    • Raveh T., Kimchi A. DAP kinase-a proapoptotic gene that functions as a tumor suppressor. Exp Cell Res 2001;264:185-192 (Pubitemid 32989091)
    • (2001) Experimental Cell Research , vol.264 , Issue.1 , pp. 185-192
    • Raveh, T.1    Kimchi, A.2
  • 43
    • 0037078325 scopus 로고    scopus 로고
    • DAP-kinase induces apoptosis by suppressing integrin activity and disrupting matrix survival signals
    • Wang W.J., Kuo J.C., Yao C.C., Chen R.H. DAP-kinase induces apoptosis by suppressing integrin activity and disrupting matrix survival signals. J Cell Biol 2002;159:169-179
    • (2002) J Cell Biol , vol.159 , pp. 169-179
    • Wang, W.J.1    Kuo, J.C.2    Yao, C.C.3    Chen, R.H.4
  • 44
    • 3042515471 scopus 로고    scopus 로고
    • DAP-kinase as a target for drug design in cancer and diseases associated with accelerated cell death
    • DOI 10.1016/j.semcancer.2004.04.008, PII S1044579X04000252
    • Bialik S., Kimchi A. DAP-kinase as a target for drug design in cancer and diseases associated with accelerated cell death. Semin Cancer Biol 2004;14:283-294 (Pubitemid 38824589)
    • (2004) Seminars in Cancer Biology , vol.14 , Issue.4 , pp. 283-294
    • Bialik, S.1    Kimchi, A.2
  • 46
    • 33644824212 scopus 로고    scopus 로고
    • 14-3-3sigma methylation in pretreatment serum circulating DNA of cisplatin-plus-gemcitabine-treated advanced non-small-cell lung cancer patients predicts survival: The Spanish Lung Cancer Group
    • Ramirez J.L., Rosell R., Taron M., Sanchez-Ronco M., Alberola V., De Las Penas R., et al. 14-3-3sigma methylation in pretreatment serum circulating DNA of cisplatin-plus-gemcitabine-treated advanced non-small-cell lung cancer patients predicts survival: The Spanish Lung Cancer Group. J Clin Oncol 2005;23:9105-9112
    • (2005) J Clin Oncol , vol.23 , pp. 9105-9112
    • Ramirez, J.L.1    Rosell, R.2    Taron, M.3    Sanchez-Ronco, M.4    Alberola, V.5    De Las Penas, R.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.